eo2401
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2019 (NCT04116658)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05589597 | Phase 1/Phase 2 (Phase 2) | Mar 31, 2023 | Enterome |
| NCT04187404 | Phase 1/Phase 2 (Phase 2) | Mar 31, 2020 | Enterome |
| NCT04116658 | Phase 1/Phase 2 (Phase 2) | Dec 31, 2019 | Covance, Enterome |
Showing 3 of 3 trials
Page 1 / 1